Sage Rhino Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.68M | Buy |
2,151
+12
| +0.6% | +$9.35K | 0.35% | 59 |
|
2025
Q1 | $1.77M | Buy |
2,139
+10
| +0.5% | +$8.26K | 0.41% | 55 |
|
2024
Q4 | $1.64M | Sell |
2,129
-21
| -1% | -$16.2K | 0.36% | 57 |
|
2024
Q3 | $1.9M | Buy |
2,150
+7
| +0.3% | +$6.2K | 0.42% | 52 |
|
2024
Q2 | $1.94M | Buy |
2,143
+24
| +1% | +$21.7K | 0.46% | 51 |
|
2024
Q1 | $1.65M | Buy |
2,119
+16
| +0.8% | +$12.4K | 0.39% | 56 |
|
2023
Q4 | $1.23M | Sell |
2,103
-30
| -1% | -$17.5K | 0.31% | 64 |
|
2023
Q3 | $1.15M | Hold |
2,133
| – | – | 0.32% | 65 |
|
2023
Q2 | $1M | Sell |
2,133
-19
| -0.9% | -$8.91K | 0.28% | 73 |
|
2023
Q1 | $739K | Buy |
2,152
+38
| +2% | +$13.1K | 0.22% | 90 |
|
2022
Q4 | $773K | Sell |
2,114
-19
| -0.9% | -$6.95K | 0.25% | 80 |
|
2022
Q3 | $690K | Sell |
2,133
-17
| -0.8% | -$5.5K | 0.28% | 63 |
|
2022
Q2 | $697K | Buy |
2,150
+10
| +0.5% | +$3.24K | 0.27% | 66 |
|
2022
Q1 | $613K | Buy |
2,140
+2
| +0.1% | +$573 | 0.19% | 101 |
|
2021
Q4 | $591K | Sell |
2,138
-12
| -0.6% | -$3.32K | 0.17% | 108 |
|
2021
Q3 | $497K | Buy |
2,150
+63
| +3% | +$14.6K | 0.15% | 107 |
|
2021
Q2 | $479K | Buy |
2,087
+42
| +2% | +$9.64K | 0.14% | 111 |
|
2021
Q1 | $382K | Buy |
2,045
+29
| +1% | +$5.42K | 0.13% | 120 |
|
2020
Q4 | $340K | Buy |
2,016
+46
| +2% | +$7.76K | 0.13% | 116 |
|
2020
Q3 | $292K | Sell |
1,970
-75
| -4% | -$11.1K | 0.14% | 117 |
|
2020
Q2 | $336K | Buy |
2,045
+118
| +6% | +$19.4K | 0.18% | 103 |
|
2020
Q1 | $267K | Buy |
1,927
+23
| +1% | +$3.19K | 0.19% | 97 |
|
2019
Q4 | $263K | Sell |
1,904
-583
| -23% | -$80.5K | 0.15% | 119 |
|
2019
Q3 | $278K | Sell |
2,487
-79
| -3% | -$8.83K | 0.17% | 109 |
|
2019
Q2 | $284K | Sell |
2,566
-144
| -5% | -$15.9K | 0.18% | 104 |
|
2019
Q1 | $352K | Buy |
+2,710
| New | +$352K | 0.23% | 89 |
|